Rhine Shen Garcia

Title: Rhine Shen Garcia: Innovator in Immune Cell Therapy

Introduction

Rhine Shen Garcia is a prominent inventor based in Santa Monica, CA (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative work on chimeric antigen receptor T cell therapy. His research focuses on developing effective treatments for malignancies, showcasing his commitment to advancing medical science.

Latest Patents

Garcia holds 1 patent for his groundbreaking work on chimeric antigen receptor T cell therapy. The patent outlines methods for treating malignancies by administering an effective dose of immune cell therapy. This includes the use of genetically modified T cell immunotherapy and methods for manufacturing such treatments. Additionally, the patent discusses ways to determine a patient's objective response to the therapy based on various patient and product attributes before and after treatment.

Career Highlights

Garcia is currently associated with Kite Pharma, Inc., a leading company in the field of cell therapy. His role at Kite Pharma allows him to collaborate with other experts in the field and contribute to the development of innovative therapies that can potentially save lives.

Collaborations

One of Garcia's notable coworkers is Vicki Plaks. Together, they work on advancing the research and application of immune cell therapies, contributing to the overall mission of improving patient outcomes in cancer treatment.

Conclusion

Rhine Shen Garcia's work in chimeric antigen receptor T cell therapy exemplifies the innovative spirit of modern medicine. His contributions are paving the way for new treatment options for patients facing malignancies.